Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRd vs Rd in Newly Diagnosed Multiple Myeloma
NCT01530594Phase 3Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jan 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by King Faisal Specialist Hospital and Research Centre. Started Jan 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01530594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530594.